News Corp Authorizes $1 Billion Stock Repurchase Program

By Tamara Parker • Friday, September 12 15:42 • Permanent Link

News Corporation has announced a repurchase program for up to an aggregate of US$1 billion of the company's Nasdaq-listed Class A common stock and Class B common stock. As of July 15, 2025, an additional US$1 billion has been authorized for the 2025 Repurchase Program. The company may purchase up to an aggregate of US$1 billion of Class A common stock and Class B common stock under the 2021 Repurchase Program and an aggregate of US$1 billion under the 2025 Repurchase Program.

The total number of +securities on issue in the class of +securities to be bought back is 375,593,195, and the total number of +securities proposed to be bought back is an aggregate of US$1 billion of Class A common stock and Class B common stock under the 2021 Repurchase Program and an aggregate of US$1 billion under the 2025 Repurchase Program.

The entity has bought back a total of 23,670,875 +securities, or in relation to which acceptances have been received, for a total consideration of US$499,880,910 as of the previous day. The highest price paid was US$30.75 on July 15, 2025, and the lowest price paid was US$14.88 on September 29, 2022.

The company is authorized to acquire up to an aggregate of US$1 billion of the Company’s Nasdaq-listed Class A common stock and Class B common stock under the 2021 Repurchase Program and an aggregate of US$1 billion under the 2025 Repurchase Program. To date, the company has purchased approximately US$757,911,821 worth of Class A and Class B shares (based on total consideration paid) under the 2021 Repurchase Program. Following these announcements, the company's shares moved -0.41%, and are now trading at a price of $29.40. For the full picture, make sure to review NEWS CORP's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.